NCT02390479

Gingival Crevicular Fluid Levels of Sclerostin, Osteoprotegerin (OPG) and RANKL in Health, Disease and After Treatment

• Status: Completed
• Phase: EARLY_Phase 1
• Study type: Interventional
• Enrollment: 54 (actual)
• Sponsor: Umut BALLI · Academic / Other
• Sex: All
• Age: 25 Years – 49 Years
• Healthy volunteers: Accepted

Summary

The primary objective of this case-control intervention study to explore the effectiveness of non surgical periodontal therapy on the gingival crevicular fluid (GCF) levels of sclerostin in patients with chronic periodontitis (CP) so as to get a more detailed insight into its diagnostic and prognostic potential as a biomarker of periodontal disease.

Detailed description

All individuals underwent a full-mouth periodontal examination, which included probing pocket depth (PPD), clinical attachment level (CAL), plaque index (PI), gingival index (GI), bleeding on probing (BOP). Individuals were categorized into three groups: individuals with clinically healthy periodontium (group 1), patients with chronic periodontitis (group 2), and group 3 consisted of the patients with chronic periodontitis (group 2), treated by scaling and root planning. GCF samples in grup 1 were taken at baseline. In group 2, GCF samples were taken before and after non- surgical periodontal treatment. Sclerostin, OPG and RANKL levels were determined using the enzyme-linked immunosorbent assay.

Conditions

• Periodontitis

Interventions

Type	Name	Description
OTHER	non surgical periodontal treatment	1. SRP under local anaesthesia, in a total of four clinical visits 2. Oral hygiene instructions including the modified Bass technique, regular toothpaste, and an appropriate interdental cleaning device with dental floss and interdental brush.

Timeline

• Start date: 2013-12-01
• Primary completion: 2014-10-01
• Completion: 2014-10-01
• First posted: 2015-03-17
• Last updated: 2015-09-30